Results 21 to 30 of about 1,896 (179)

Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention. [PDF]

open access: yesAm J Trop Med Hyg
ABSTRACT. Seasonal malaria chemoprevention (SMC) for children under 5 years of age for up to four monthly cycles during malaria transmission season was recommended by the WHO in 2012 and has been implemented in 13 countries in the Sahel, reaching more than 30 million children annually.
Thwing J   +3 more
europepmc   +3 more sources

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial

open access: goldPLOS ONE, 2018
Seasonal malaria chemoprevention (SMC), the administration of complete therapeutic courses of antimalarials to children aged 3-59 months during the malaria transmission season, is a new strategy recommended by the World Health Organization (WHO) for malaria control in Sahelian countries such as Mali with seasonal transmission.
Amadou Barry   +10 more
openalex   +6 more sources

Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach. [PDF]

open access: yesMalar J, 2023
Abstract Background SMC was adopted in Nigeria in 2014 and by 2021 was being implemented in 18 states, over four months between June and October by 143000 community drug distributors (CDDs) to a target population of 23million children.
Ogbulafor N   +16 more
europepmc   +4 more sources

The use of video job-aids to improve the quality of seasonal malaria chemoprevention delivery. [PDF]

open access: yesPLOS Digit Health, 2022
Mobile phones are increasingly used in community health programmes, but the use of video job-aids that can be displayed on smart phones has not been widely exploited. We investigated the use of video job-aids to support the delivery of seasonal malaria chemoprevention (SMC) in countries in West and Central Africa. The study was prompted by the need for
Scott S   +36 more
europepmc   +5 more sources

Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali [PDF]

open access: yesMalaria Journal, 2017
Background Seasonal malaria chemoprevention (SMC) is a new strategy to reduce malaria burden in young children in Sahelian countries. It consists of the administration of full treatment courses of sulfadoxine–pyrimethamine plus amodiaquine to children at
Almahamoudou Mahamar   +12 more
doaj   +3 more sources

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention

open access: yesBMJ Open, 2020
Introduction Seasonal malaria chemoprevention (SMC), with sulphadoxine–pyrimethamine plus amodiaquine (SP+AQ) is effective but does not provide complete protection against clinical malaria.
Ismaila Thera   +18 more
doaj   +4 more sources

Estimating the potential public health impact of seasonal malaria chemoprevention in African children [PDF]

open access: hybridNature Communications, 2012
Seasonal malaria chemoprevention, previously known as intermittent preventive treatment in children, is highly effective in areas with a short malaria transmission season. Here we assess seasonality in malaria incidence data and define a predictor of seasonality based on rainfall.
Matthew Cairns   +7 more
openalex   +9 more sources

Effect of routine seasonal malaria chemoprevention on malaria trends in children under 5 years in Dangassa, Mali [PDF]

open access: yesMalaria Journal, 2020
Background Seasonal malaria chemoprevention (SMC) is a new strategy to prevent malaria in children under 5 years old. It has been recommended by the World Health Organization since 2012 in malaria-endemic areas with seasonal transmission.
Drissa Konaté   +15 more
doaj   +4 more sources

Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria [PDF]

open access: yesMalaria Journal
Background As part of implementation quality standards, community distributors are expected to ensure that only age-eligible children (aged 3–59 months) receive seasonal malaria chemoprevention (SMC) medicines during monthly campaigns.
Taiwo Ibinaiye   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy